Somatostatin and dopamine receptors

被引：8

作者：

Ferone, Diego ^{[1
]}

机构：

[1] Univ Genoa, Dept Endocrinol & Med Sci DiSEM, Genoa, Italy

来源：

TUMORI | 2010年 / 96卷 / 05期

关键词：

PITUITARY-ADENOMAS; IN-VITRO; EXPRESSION; EFFICACY; GROWTH; ANALOG; MOLECULES; TUMORS; GH;

D O I：

10.1177/030089161009600531

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The discovery of the new properties of SSRs and DRs has led to a renewed interest in agents targeting these receptors and has opened new perspectives for medical treatment of patients with pituitary and neuroendocrine tumors resistant to the "classical", currently available analogs. Moreover, SSRs and DRs crosstalk at membrane level may trigger alternative intracellular pathways or enhance the signalling for the control of cell growth. New somatostatin analogs and hybrid molecules, which display a broader and different spectrum of activities compared to conventional analogs, seem to be a promising therapeutic alternative for the control of hormone secretion and, hopefully, to reduce tumor burden. Receptor profile characterization is crucial for the accurate selection of patients potentially responsive to a given therapy. Free full text available at www.tumorionline.it

引用

页码：802 / 805

页数：4

共 15 条

[1] Dimerization: An emerging concept for G protein-coupled receptor ontogeny and function [J].

Angers, S ;

Salahpour, A ;

Bouvier, M .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2002, 42 :409-435

[2] Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation [J].

Ferone, D ;

Arvigo, M ;

Semino, C ;

Jaquet, P ;

Saveanu, A ;

Taylor, JE ;

Moreau, JP ;

Culler, MD ;

Albertelli, M ;

Minuto, F ;

Barreca, A .

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2005, 289 (06) :E1044-E1050

[3] Correlation of in Vitro and in Vivo somatotropic adenoma responsiveness to somatostatin analogs and dopamine agonists with immunohistochemical evaluation of somatostatin and dopamine receptors and electron microscopy [J].

Ferone, Diego ;

de Herder, Wouter W. ;

Pivonello, Rosario ;

Kros, Johan M. ;

van Koetsveld, Peter M. ;

de Jong, Ton ;

Minuto, Francesco ;

Colao, Annamaria ;

Lamberts, Steven W. J. ;

Hofland, Leo J. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (04) :1412-1417

[4] The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology [J].

Ferone, Diego ;

Gatto, Federico ;

Arvigo, Marica ;

Resmini, Eugenia ;

Boschetti, Mara ;

Teti, Claudia ;

Esposito, Daniela ;

Minuto, Francesco .

JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2009, 42 (5-6) :361-370

[5] Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study [J].

Florio, Tullio ;

Barbieri, Federica ;

Spaziante, Renato ;

Zona, Gianluigi ;

Hofland, Leo J. ;

van Koetsveld, Peter M. ;

Feelders, Richard A. ;

Stalla, Guenter K. ;

Theodoropoulou, Marily ;

Culler, Michael D. ;

Dong, Jesse ;

Taylor, John E. ;

Moreau, Jacques-Pierre ;

Saveanu, Alexandru ;

Gunz, Ginette ;

Dufour, Henry ;

Jaquet, Philippe .

[6] The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro [J].

Hofland, LJ ;

van der Hoek, J ;

van Koetsveld, PM ;

de Herder, WW ;

Waaijers, M ;

Sprij-Mooij, D ;

Bruns, C ;

Weckbecker, G ;

Feelders, R ;

van der Lely, AJ ;

Beckers, A ;

Lamberts, SWJ .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (04) :1577-1585

[7] Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy [J].

Jaquet, P ;

Gunz, G ;

Saveanu, A ;

Dufour, H ;

Taylor, J ;

Dong, J ;

Kim, S ;

Moreau, JP ;

Enjalbert, A ;

Culler, MD .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 153 (01) :135-141

[8] Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell lines [J].

Kidd, Mark ;

Drozdov, Ignat ;

Joseph, Richard ;

Pfragner, Roswitha ;

Culler, Michael ;

Modlin, Irv .

CANCER, 2008, 113 (04) :690-700

[9] The analysis of quantitative expression of somatostatin and dopamine receptors in gastro-entero-pancreatic tumours opens new therapeutic strategies [J].

O'Toole, Dermot ;

Saveanu, Alexandru ;

Couvelard, Anne ;

Gunz, Ginette ;

Enjalbert, Alain ;

Jaquet, Philippe ;

Ruszniewski, Philippe ;

Barlier, Anne .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 155 (06) :849-857

[10] Homo- and heterodimerization of somatostatin receptor subtypes -: Inactivation of sst3 receptor function by heterodimerization with sst2A [J].

Pfeiffer, M ;

Koch, T ;

Schröder, H ;

Klutzny, M ;

Kirscht, S ;

Kreienkamp, HJ ;

Höllt, V ;

Schulz, S .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (17) :14027-14036

← 1 2 →